Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment

Overview of attention for article published in The Patient - Patient-Centered Outcomes Research, June 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#48 of 528)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet

twitter: 12 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 12 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Patients weigh up priorities for adjuvant immunotherapy in melanoma

Thelimbic, 03 Jul 2023

Most patients with resected stage III melanoma would opt for adjuvant checkpoint inhibitor immunotherapy if given the choice…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.